R. Thadhani et al., A prospective study of pregravid oral contraceptive use and risk of hypertensive disorders of pregnancy, CONTRACEPT, 60(3), 1999, pp. 145-150
Oral contraceptive use is associated with hypertension, dyslipidemias, and
insulin resistance, all of which also characterize hypertensive disorders o
f pregnancy. In this prospective cohort study, the association of oval cont
raceptive use before pregnancy and the risk of gestational hypertension and
preeclampsia was assessed. Between 1991 and 1995, 3973 nulliparous women w
ho reported their first pregnancy lasting greater than or equal to 6 months
were studied. Pregravid exposures were collected by biennial mailed questi
onnaires, and cases were confirmed by medical record review Recent oral con
traceptive use was defined as use within 2 years of pregnancy. Proportional
hazards analysis as used to adjust for potential confounding variables. Du
ring the 4 years of follow-up, 133 (3.3%) women with gestational hypertensi
on and 62 (1.6%) with preeclampsia were identified. Twenty-five percent of
women who did not develop these disorders were recent users of oral contrac
eptives, compared with 19% (p = 0.12) of women who developed gestational hy
pertension and 30% (p = 0.38) who developed preeclampsia. Mean duration of
prior oral contraceptive use was similar for cases and noncases. Compared w
ith never and past users, the multivariate relative risk among recent users
for developing gestational hypertension was 0.7 (95% confidence interval (
CI), 0.4-1.0) and for preeclampsia was 1.3 (95% CI, 0.8-2.4). Among recent
users who had used oral contraceptives for greater than or equal to 8 years
, the relative risk for gestational hypertension was 0.6 (95% CI, 0.3-1.2)
and for preeclampsia was 2.1 (95% CI, 1.1-4.2). When the analysis was restr
icted to women who had never smoked, the risk for gestational hypertension
was 0.2 (95% CI, 0.1-0.9) and for preeclampsia was 4.1 (95% CI, 1.9-8.7). T
hus, recent use of oral contraceptives was associated with a reduced risk f
or developing gestational hypertension. In contrast, there was a suggestion
that recent use was associated with an increased risk of developing preecl
ampsia, but only among women who had used these agents for greater than or
equal to 8 years.